関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | 1-Bromo-3-fluorobenzene | HCID 14082 | — |
| 反応物 | methyl 2-morpholino-4-oxo-8-(pyrrolidin-2-yl)-4H-chromene-6-carboxylate | HCID 86672405 | — |
| 試薬 | Cesium carbonate | HCID 10796 | — |
| 触媒 | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| 触媒 | Palladium (II) acetate | HCID 4144353 | — |
| 溶媒 | 1,4-Dioxane | HCID 31275 | — |
| 生成物 | Methyl 8-[1-(3-fluorophenyl)pyrrolidin-2-yl]-2-morpholin-4-yl-4-oxochromene-6-carboxylate | HCID 89051670 | 78.55% |
反応手順
diacetoxypalladium (3.33 mg, 0.01 mmol) was added to a stirred mixture of methyl 2-morpholino-4-oxo-8-(pyrrolidin-2-yl)-4H-chromene-6-carboxylate (121 mg, 0.34 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (16.61 mg, 0.03 mmol), 1-bromo-3-fluorobenzene (0.047 ml, 0.42 mmol) and cesium carbonate (165 mg, 0.51 mmol) suspended in 1,4-dioxane (3.329 ml). The resulting suspension was degased with argon and then stirred at 100 °C for 20 hours _(_ _UPLC/MS O/N showed that the SM was almost consumed)._ The reaction mixture was allowed to cool to room temperature, the crude product was adsorbed on silica gel and purified by flash chromatography on silica gel eluting with 0 to 7% Propanol-CH2Cl2. The solvent was evaporated to dryness to afford methyl 8-(1-(3-fluorophenyl)pyrrolidin-2-yl)-2-morpholino-4-oxo-4H-chromene-6-carboxylate (120 mg, 79 %) as a yellow oil which solidified on standing.
情報源と証拠
| 出典データセット | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-f5b45295d816488bbc3b0ba43fcc57fb |
|---|
| 出典メモ | 750 AstraZeneca ELN dataset |
|---|